GITR antibodies, methods, and uses
US10730950B2 · kind B2 · utility
1Cited by
14References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2017 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Mar 8, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibodies that specifically bind to GITR. Also described are related polynucleotides capable of encoding the provided GITR-specific antibodies or antigen-binding fragments, cells expressing the provided antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled antibodies or antigen-binding fragments. In addition, methods of using the provided antibodies are described. For example, the provided antibodies may be used to enhance an immune response in a subject against cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.